Titan Medical Inc.
TMDIF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $17,955 | $0 | $19,916 | $21,057 |
| % Growth | – | -100% | -5.4% | – |
| Cost of Goods Sold | $189 | $826 | $0 | $0 |
| Gross Profit | $17,766 | -$826 | $19,916 | $21,057 |
| % Margin | 98.9% | – | 100% | 100% |
| R&D Expenses | $327 | $31,020 | $37,621 | $8,356 |
| G&A Expenses | $8,362 | $11,764 | $12,790 | $7,629 |
| SG&A Expenses | $8,326 | $11,151 | $12,317 | $8,032 |
| Sales & Mktg Exp. | -$36 | -$613 | -$473 | $141 |
| Other Operating Expenses | -$1,199 | $0 | $605 | $0 |
| Operating Expenses | $7,454 | $42,171 | $49,938 | $16,389 |
| Operating Income | $10,312 | -$42,997 | -$30,714 | $4,418 |
| % Margin | 57.4% | – | -154.2% | 21% |
| Other Income/Exp. Net | $2,266 | $2,087 | $16,043 | -$29,881 |
| Pre-Tax Income | $7,105 | -$40,910 | -$14,672 | -$25,462 |
| Tax Expense | $24 | -$54 | $56 | $0 |
| Net Income | $6,953 | -$40,856 | -$14,727 | -$25,462 |
| % Margin | 38.7% | – | -73.9% | -120.9% |
| EPS | 0.061 | -0.37 | -0.14 | -0.38 |
| % Growth | 116.4% | -164.3% | 63.2% | – |
| EPS Diluted | 0.061 | -0.37 | -0.14 | -0.38 |
| Weighted Avg Shares Out | 116,841 | 111,522 | 108,444 | 67,009 |
| Weighted Avg Shares Out Dil | 116,841 | 111,522 | 108,444 | 67,009 |
| Supplemental Information | – | – | – | – |
| Interest Income | $308 | $145 | $73 | $29 |
| Interest Expense | $221 | $148 | $185 | $1,091 |
| Depreciation & Amortization | $189 | $826 | $693 | $249 |
| EBITDA | $7,519 | -$39,942 | -$13,855 | -$22,844 |
| % Margin | 41.9% | – | -69.6% | -108.5% |